Inovalon, which provides healthcare data and analytics to pharmas, payors and providers, filed on Tuesday with the SEC to raise up to $500 million in an initial public offering. The Bowie, MD-based company, which was founded in 1998 and booked $336 million in sales for the 12 months ended September 30, 2014, plans to list on the NASDAQ under the symbol INOV. Inovalon initially filed confidentially on October 10, 2014. Goldman Sachs, Morgan Stanley, Citi, BofA Merrill Lynch and UBS Investment Bank are the joint bookrunners on the deal. No pricing terms were disclosed.
